These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20393298

  • 1. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S, Brinkmann R, Windeck T.
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Use of Panzytrat in the replacement therapy of exocrine pancreatic insufficiency (an analytical review)].
    Karamysheva EI, Lobanova EG.
    Eksp Klin Gastroenterol; 2002 May; (4):47-50, 132. PubMed ID: 12503276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
    Bolshova EV, Lukashuk IV, Lukashuk VD.
    Lik Sprava; 2015 May; (1-2):167-9. PubMed ID: 26118067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comment on: "Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS".
    Petersen KU.
    Drugs R D; 2021 Dec; 21(4):467-468. PubMed ID: 34669165
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS.
    Maev IV, Kucheryavyy YA, Gubergrits NB, Bonnacker I, Shelest EA, Janssen-van Solingen GP, Domínguez-Muñoz JE.
    Drugs R D; 2020 Dec; 20(4):369-376. PubMed ID: 33211277
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF, Vidailhet M, Le Luyer B, Douchain F, Jehanne M, Clavel R, Guillot M.
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I, Kubias K, Duda M.
    Acta Physiol Hung; 1992 Jan; 80(1-4):417-21. PubMed ID: 1364280
    [Abstract] [Full Text] [Related]

  • 17. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
    Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H.
    Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Canine exocrine pancreatic insufficiency treated with porcine pancreatic extract.
    Kim JW, Jung DI, Kang BT, Kim HJ, Park C, Park EH, Lim CY, Park HM.
    J Vet Sci; 2005 Sep; 6(3):263-6. PubMed ID: 16131834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.